Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Grows By 85.5%

Virax Biolabs Group Limited (NASDAQ:VRAX) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 164,900 shares, an increase of 85.5% from the December 15th total of 88,900 shares. Currently, 4.1% of the shares of the stock are short sold. Based on an average daily volume of 1,790,000 shares, the days-to-cover ratio is currently 0.1 days.

Virax Biolabs Group Stock Down 3.8 %

Shares of VRAX stock opened at $2.29 on Wednesday. The stock has a fifty day moving average price of $2.02 and a 200 day moving average price of $2.14. Virax Biolabs Group has a 1 year low of $0.60 and a 1 year high of $9.00.

About Virax Biolabs Group

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.